Condition
Obesity and Type 2 Diabetes clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Obesity and Type 2 Diabetes clinical trials that are recruiting, at sites in 4 countries (most in United States (3), South Korea (1), Singapore (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Obesity and Type 2 Diabetes clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| HIIT versus time-restricted eating to lower type 2 diabetes risk in adolescents and young adults | — | Syracuse, New York | Recruiting | Oct 10, 2025 |
| Telehealth program for preventing diabetes in Hispanic teens | — | Houston, Texas | Recruiting | Apr 24, 2025 |
| Telehealth program for weight management and related health issues | — | Singapore | Recruiting | Mar 21, 2025 |
| Investigating the impact of KATP channel loss on insulin secretion in type 2 diabetes | — | St Louis, Missouri | Recruiting | Feb 17, 2025 |
| Effects of enavogliflozin on heart and blood vessel function in obese patients | Phase 4 | Seoul | Recruiting | Jan 17, 2025 |
| Investigating inflammation's role in heart disease and diabetes | — | Aarhus | Recruiting | Dec 30, 2024 |
All recruiting trials (6)
-
HIIT versus time-restricted eating to lower type 2 diabetes risk in adolescents and young adults
This project will test whether 4 weeks of high-intensity interval training or time-restricted eating improves heart and metabolic health in adolescents and young adults with overweight or obesity.
-
Telehealth program for preventing diabetes in Hispanic teens
This study is testing a new online program to help Hispanic teens who are overweight prevent diabetes by making it easier for them and their families to join in.
-
Telehealth program for weight management and related health issues
This study is testing a new telehealth program for weight management to see if it helps obese adults with type 2 diabetes and liver issues lose weight and improve their health better than traditional in-person programs.
-
Investigating the impact of KATP channel loss on insulin secretion in type 2 diabetes
This study is testing how a medication called glipizide affects insulin release in people with type 2 diabetes to see if losing certain channels in the body makes it harder to manage blood sugar, especially in those who are obese.
-
Effects of enavogliflozin on heart and blood vessel function in obese patients
This study tests if the drug enavogliflozin can improve heart and blood vessel function in obese patients and help them exercise better.
-
Investigating inflammation's role in heart disease and diabetes
This study is testing how inflammation affects heart disease and diabetes in people who are healthy compared to those who are severely obese, to see if it can help identify who might benefit from new treatments.
Related topics
Quick answers
How many Obesity and Type 2 Diabetes clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (3 trials), South Korea (1 trial), Singapore (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.